Michael GrabnerFollowCarelon Research1 paperORCID 0000-0002-6521-1007 ↗OpenAlex ↗PapersJournal of Managed Care & Specialty PharmacyHumans·30 SepReal-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes
Journal of Managed Care & Specialty PharmacyHumans·30 SepReal-world treatment patterns and cost per patient achieving treatment targets among tirzepatide and semaglutide initiators in US patients with type 2 diabetes